XCUR

Exicure Inc

• TipRanks·05/15 23:37

  Exicure delays quarterly filing, trims quarterly loss

• PUBT·05/15 20:03

  Exicure delays filing quarterly report, seeks five-day extension under SEC rules

• NASDAQ·04/23 15:29

  Exicure To Co-develop Burixafor With Adbiotech For Multiple Indications

• PUBT·04/22 23:54

  Exicure partners with Adbiotech to co-develop Burixafor combination therapies

• Reuters·04/22 23:54

  EXICURE ANNOUNCES CO-DEVELOPMENT AGREEMENT WITH ADBIOTECH FOR BURIXAFOR (GPC-100)

• TipRanks·04/10 21:05

  Exicure Strengthens Leadership With New COO and Director

• Reuters·04/10 20:17

  Exicure names Young Seung Ko chief operating officer

• Benzinga·04/09 12:05

  12 Health Care Stocks Moving In Thursday's Pre-Market Session

• TipRanks·04/02 21:55

  Exicure Reaches Preliminary Settlement in Derivative Lawsuits

• Reuters·04/02 20:03

  EXICURE INC - ANNOUNCES SETTLEMENT OF STOCKHOLDER DERIVATIVE ACTION PER MARCH 18, 2026 STIPULATION

• Benzinga·04/02 20:02

  Exicure Reaches Settlement In Shareholder Derivative Lawsuit, Agrees To Governance Reforms And $675K Legal Fee Payment

• Reuters·04/02 20:01

  Exicure reaches settlement in stockholder derivative litigation, adopts governance reforms

• TipRanks·03/27 21:36

  Exicure Announces Routine Board and Audit Committee Change

• Reuters·03/27 20:41

  Exicure board changes; Sangjin Yeo resigns from board and audit committee effective March 27, 2026

• Seeking Alpha·03/26 09:55

  Exicure GAAP EPS of -$0.79